Neuropharmacological studies on selective monoamine oxidase A and B inhibitors.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D003010:Clorgyline / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D006991:Hypnosis, Anesthetic; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy; D012642:Selegiline / Q000494:pharmacology
D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D003010:Clorgyline; D009526:Nialamide